@klipskaMD profile picture
Kasia Lipska @klipskaMD

Endocrinologist at Yale. Diabetes outcomes researcher.

Joined October 2015
  • Tweets 135
  • Following 104
  • Followers 540
4 Photos and videos
Recent policies to cap out-of-pocket payments, require rebates on price hikes, & allow government negotiation. From CalRx to federal legislation, the fight for affordable medications! diabetesjournals.org/care/ar…

Lessons From Insulin: Policy Prescriptions for Affordable Diabetes and Obesity Medications

Escalating insulin prices have prompted public scrutiny of the practices of drug manufacturers, pharmacy benefit managers, health insurers, and pharmacies

diabetesjournals.org
1
2
342
Lessons From Insulin: Policy Prescriptions for Affordable Diabetes and Obesity Medications diabetesjournals.org/care/ar…

Lessons From Insulin: Policy Prescriptions for Affordable Diabetes and Obesity Medications

Escalating insulin prices have prompted public scrutiny of the practices of drug manufacturers, pharmacy benefit managers, health insurers, and pharmacies

diabetesjournals.org
215
Kasia Lipska retweeted
Joseph Ross@jsross119
8 Jun 2022
Friends, colleagues, alumni, please help me spread the word! Applications for the @NationalCSP are due July 15th. Training physicians/PhD nurses to advance health and healthcare for patients and communities through scholarship and action. More info here: nationalcsp.org/apply
21
22
Kasia Lipska retweeted
Rozalina (Grubina) McCoy, MD MS@RozalinaMD
27 Jun 2022
So proud of @DavidHJiang for leading this improving work reimagining quality measurement in #diabetes. We must focus on all domains of quality - effectiveness, equity, efficiency, safety, timeliness - to ensure optimal care & outcomes for all.
Health Affairs
@Health_Affairs
27 Jun 2022
Replying to @Health_Affairs
3️⃣ @MayoClinic's David Jiang and coauthors propose the adoption of new quality measures and modernization of existing ones.,arguing for alignment of measures with the six domains of quality as defined by the National Academy of Medicine. #DiabetesAndHealth bit.ly/3A6DHRU
1
10
Honored to work with @BayleeBakkila and @SanjaybMDPhD on this study. Copay caps are important but $35 per month may still be out of reach to many low income families.
This tweet is unavailable
Catastrophic Spending On Insulin In The United States, 2017–18 | Health Affairs Journal healthaffairs.org/doi/10.137…

Catastrophic Spending On Insulin In The United States, 2017–18 | Health Affairs Journal

Insulin is considered an essential medicine for people with diabetes, but its price has doubled during the past decade, posing substantial financial barriers to patients in the US. In this article we...

healthaffairs.org
1
Kasia Lipska retweeted
JAMA Health Forum@JAMAHealthForum
5 Jun 2020
Cohort study finds multi-morbidity (esp in young people), prior #hypoglycemia, & #diabetes meds are strongly associated with severe hypoglycemia needing ED/hospital care ja.ma/2x2FSIf @RozalinaMD @klipskaMD @nilaydshah1
2
4
Kasia Lipska retweeted
James Elliott@Jandelliott
2 Jun 2020
New in @JAMAInternalMed "Expensive Insulin—The Epicenter of a Large, Life-Threatening Problem" by @drnallypants @klipskaMD; points out issues in existing out of pocket studies that cause under-estimation of problem jamanetwork.com/journals/jam… #insulin4all

Expensive Insulin—The Epicenter of a Large, Life-Threatening Problem

For millions of people with diabetes, including those with type 1 diabetes, access to insulin can be a matter of life and death. Shortly after discovering insulin in 1921, Banting, Best, and Collip...

jamanetwork.com
3
3
Kasia Lipska retweeted
Yale Internal Medicine@YaleIMed
21 Feb 2020
"This study's finding -- that people may be getting drugs in unregulated places -- is a symptom of a failing system. #Insulin & other drugs need to be more affordable for patients," Dr. Kasia Lipska said in usnews.com/news/health-news/… @usnews @klipskaMD @YaleMed #YaleEndocrinology
3
2
Expensive Insulin—The Epicenter of a Large, Life-Threatening Problem ja.ma/3002kNZ led by Laura Nally. #insulin4all #t1international

2
8
10
Kasia Lipska retweeted
Connecticut #insulin4all@CTinsulin4all
17 Apr 2020
Reminder that passing #insulin4all legislation NOW is a critical response to #COVID19. Our chapter has seen a huge increase in needs for insulin, diabetes related supplies, and healthcare. Lack of access and high costs were an issue before and have now been magnified.
2
11
16
Kasia Lipska retweeted
Scott Hechinger
@ScottHech
28 Mar 2020
MY GOD: Today’s numbers (March 28, 2020) for Rikers just released by Legal Aid Society. Outbreak spreading exponentially. Now up to 132. The *infection rate is by far the highest in the world.* This is only getting worse. @NYGovCuomo: Release those you promised to release & more.
69
1,242
1,857
Kasia Lipska retweeted
Jake Halpern@JakeHalpern
26 Mar 2020
Introducing the ‘Grandparents’ Academy’ — A way to tap the wisdom and knowledge of our elders and keep our children from losing their minds. (My latest in the NYT) nytimes.com/2020/03/26/opini…

1
6
13
Great opportunity to share comments on how the federal govt could do more for people with diabetes: regulations.gov/document?D=H…
2
On the 4th day of Christmas, my true {evidence sleuthing, critically appraising, unconflicted} L❤️VE gave to meeeeee (& you): challenge the idolatry of the surrogate marker! See Yukdin @klipskaMD @vmontori bmj.com/content/343/bmj.d799… #ebm #meded #FOAMed @BCCFP @UBCMeds @UBCDFP

The idolatry of the surrogate

Easier to measure surrogate outcomes are often used instead of patient important outcomes such as death, quality of life, or functional capacity when assessing treatments. John Yudkin , Kasia Lipska...

bmj.com
Therapeutics Initiative (TI)@Drug_Evidence
19 Dec 2019
Day 4🎄#TI12daysEBM☃️ ❓this statement: “Lowering LDL is always good” If a study shows high LDL ↗️ CV risk, it doesn't mean lowering it is a good idea. Beware surrogate markers! More: bit.ly/2AHRIpt #cholesterol #statins #surrogatemarkers #TIEvidence #DrugEvidence
3
7
Kasia Lipska retweeted
kerendo@ker_endo
11 Dec 2019
Benefits and harms of intensive glycemic control in patients with type 2 diabetes bmj.com/content/367/bmj.l588…

Benefits and harms of intensive glycemic control in patients with type 2 diabetes

Diabetes is a major and costly health concern worldwide, with high morbidity, disability, mortality, and impaired quality of life. The vast majority of people living with diabetes have type 2...

bmj.com
3
3
Kasia Lipska retweeted
Rene Rodriguez@ReneRdzGtz
5 Nov 2019
Benefits and harms of intensive glycemic control in patients with type 2 diabetes bmj.com/content/367/bmj.l588… @vmontori @doctorjuanpa @klipskaMD @RozalinaMD

Benefits and harms of intensive glycemic control in patients with type 2 diabetes

Diabetes is a major and costly health concern worldwide, with high morbidity, disability, mortality, and impaired quality of life. The vast majority of people living with diabetes have type 2...

bmj.com
12
25
Kasia Lipska retweeted
Marjorie Rosenthal@marjoriesue
23 Sep 2019
My #graphicnarrative about my cancer, my daughters, my mother and me. #graphicmedicine #cancersurvivor annals.org/aim/fullarticle/2…
2
16
55
Kasia Lipska retweeted
Jillian@T1dchick_
15 Sep 2019
The mother @NSmithholt12 of Alec was arrested by Indianapolis Police just now for her protest outside @LillyPad. Protesting for affordable insulin. Alec was rationing his insulin because of the high cost and died 810 days ago. #Insulin4all
0:37
15
163
262
Kasia Lipska retweeted
Cary Gross@cpgYALE
29 Aug 2019
In this age of empowering patients, why are providers so reluctant to allow patients access to their own medical records? Crazy - and unethical. n.pr/2L9Sf8m Thanks @hmkyale for shedding light.

Opinion: It's Your Right To See Your Medical Records. It Shouldn't Be This Hard To Do

Hospitals and other health care companies often make it hard — and pricey — to get access to your medical data. It doesn't have to be this way.

npr.org
2
15
45
Load more